Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Compare Virological Response to 0.5 mg Daily Versus 1.0 mg Daily Oral Doses of Entecavir in Chronic Hepatitis B Virus Infection Related Decompensated Cirrhosis

NCT03345498 is registered in ClinicalTrials.gov with Sanjay Gandhi Postgraduate Institute of Medical Sciences as lead sponsor.

NCT NCT03345498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03345498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Compare Virological Response to 0.5 mg Daily Versus 1.0 mg Daily Oral Doses of Entecavir in Chronic Hepatitis B Virus Infection Related Decompensated Cirrhosis
Lead sponsor
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Phase
Observational
Overall status
Completed
Start date
January 1, 2017
Completion date
December 31, 2018
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, liver cirrhosis